๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Urologic Cancer

Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer NCT03379909Phase 23 sites๐Ÿ“ Nijmegen๐Ÿ“ Rotterdam๐Ÿ“ Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AMโ€ฆ ยท Tests: Metformin A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor Incyte Corporation ยท Tests: INCA036873 WIRE - Novel Treatments in Renal Cell Cancer NCT03741426Phase 27 sites๐Ÿ“ Cambridge๐Ÿ“ Edinburgh๐Ÿ“ Exeter CCTU- Cancer Theme ยท Tests: Olaparib, Cediranib, Volrustomig, Rilvegostomig Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health Cerebrovascular Disease: Quality of Life (CODE: QoL) NCT06443268n/a1 site๐Ÿ“ Zurich University of Zurich ยท Tests: questionnaire, hair samples, blood samples, clinical exam Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell NCT07062549Phase 11 site๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: 111In-XYIMSR-01 Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers NCT03413982n/a1 site๐Ÿ“ Kansas City University of Kansas Medical Center ยท Tests: Registry Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer NCT04823923NA5 sites๐Ÿ“ Marseille๐Ÿ“ Montpellier๐Ÿ“ Montpellier Institut du Cancer de Montpellier - Val d'Aurelle ยท Tests: blood sampling for ITK dosage Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment NCT06679920NA2 sites๐Ÿ“ Amsterdam๐Ÿ“ Amsterdam Amsterdam UMC ยท Tests: Optical coherence tomography Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS) NCT06721260n/a2 sites๐Ÿ“ Kansas City๐Ÿ“ Kansas City University of Kansas Medical Center Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC) NCT07359235Phase 11 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: KD01(the recombinant oncolytic adenovirus) A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites๐Ÿ“ Beverly Hills๐Ÿ“ San Francisco๐Ÿ“ Westwood, Los Angeles Fore Biotherapeutics ยท Tests: Plixorafenib 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: 18F-T2 PET/CT Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy NCT04442724NA3 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Boston Cedars-Sinai Medical Center ยท Tests: Fiducial marker placement, Multiparametric MRI (mpMRI) Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology NCT05756569Phase 24 sites๐Ÿ“ Atlanta๐Ÿ“ Atlanta๐Ÿ“ Atlanta Emory University ยท Tests: Biospecimen Collection, Computed Tomography, Enfortumab Vedotin, Magnetic Resonance Imaging, Pembrolizumab Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer NCT06889623NA1 site๐Ÿ“ Shanghai Changhai Hospital ยท Tests: Immediate postoperative chemotherapy A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) NCT07222488Phase 1, Phase 217 sites๐Ÿ“ Bakersfield๐Ÿ“ New Brunswick๐Ÿ“ Myrtle Beach Merck Sharp & Dohme LLC ยท Tests: MK-3120 Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma NCT07067905EARLY Phase 11 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: 68Ga-XT771 CONFIRM: Magnetic Resonance Guided Radiation Therapy NCT04368702NA2 sites๐Ÿ“ Boston๐Ÿ“ Boston Brigham and Women's Hospital ยท Tests: Viewray MRIdianยฎ Linac Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma NCT07223541Phase 21 site๐Ÿ“ Oklahoma City University of Oklahoma ยท Tests: Cemiplimab 350 MG Intravenous Solution, Fianlimab 1600 MG Intravenous Solution A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing NCT07036731NA1 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Urine biomarker -Guided without reTURBT Study on the Effects of Drugs That Modulate the Endocannabinoid System on Spontaneous and Induced Contractility of the Human Detrusor Muscle NCT07545694n/a1 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS A Study of Ward Admissions for Haematuria NCT07395037n/a1 site๐Ÿ“ London British Urology Researchers in Surgical Training ยท Tests: Inpatient work-up and management Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer NCT07234656n/a3 sites๐Ÿ“ Aalborg๐Ÿ“ Aarhus๐Ÿ“ Herning Brigitta Rasmussen Villumsen ยท Tests: Phase 1: Establishment of a patient-partner panel, Phase 2: Feasibility testing of FCR questions, mode of administratioโ€ฆ Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study NCT05361720Phase 26 sites๐Ÿ“ Duarte๐Ÿ“ Orange๐Ÿ“ Cleveland Vanderbilt-Ingram Cancer Center ยท Tests: Cabozantinib, Ipilimumab, Nivolumab Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma NCT06676527n/a1 site๐Ÿ“ Nanjing Jinling Hospital, China ยท Tests: Follow-up study of the treated cohort Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-Trial NCT06720532n/a1 site๐Ÿ“ Munich Hannah Schaefer ยท Tests: characterization of renal function., Handgrip strength test, Questionaires Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC) NCT05931393Phase 21 site๐Ÿ“ Dallas University of Texas Southwestern Medical Center ยท Tests: Cabozantinib 80 MG VSV-IFNฮฒ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma NCT07510334Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Nivolumab Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma NCT06211114Phase 22 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Peking University Cancer Hospital & Institute ยท Tests: PD-(L)1 inhibitor, Axitinib
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy